VERASTEM, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.5 USD | -5.19% |
|
-2.95% | +41.28% |
| 09/05 | Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 18/04 | Verastem Names John Hayslip as Chief Medical Officer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERASTEM, INC. | Bio Therapeutic Drugs | -5.19% | -2.95% | +41.28% | +112.96% | -37.36% | 29Cr |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- VSTM Stock
- Charts Verastem, Inc.
- Comparison Chart
